Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Robin K Kelley"'
Autor:
David Goldstein, Richard Hubner, Angela Lamarca, Lipika Goyal, Junji Furuse, Tanios Bekaii-Saab, Jennifer Knox, Mairéad G McNamara, Juan Valle, Rachna Shroff, Chigusa Morizane, Lorenza Rimassa, John Bridgewater, Timothy Jacobs, Anna D Wagner, Markus Moehler, Maeve Lowery, Robin K Kelley
Publikováno v:
BMJ Open, Vol 12, Iss 10 (2022)
Objectives Female physicians in medicine are increasing, but disparities in female authorship exist. The aim of this study was to characterise factors associated with female first (FF) and female senior (SF) authorship in later phase systemic oncolog
Externí odkaz:
https://doaj.org/article/01c4ef9a216d47869af0aedf52dbfa7c
Autor:
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253671 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0222259.].
Externí odkaz:
https://doaj.org/article/2995cf4239874373a2d5d26500aa62c2
Autor:
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0222259 (2020)
BackgroundTransforming growth factor beta (TGF-β) signalling is involved in the development of hepatocellular carcinoma (HCC). We followed changes in biomarkers during treatment of patients with HCC with the TGF-βRI/ALK5 inhibitor galunisertib.Meth
Externí odkaz:
https://doaj.org/article/b94571adec37493990e021bf220fbe7b
Autor:
Michael Li, Lindsay M. Hannan, Lipika Goyal, Andrea G. Bocobo, Anna L. Parks, Kelly Bauer, Islam Baiev, Caroline Dinicola, John D. Gordan, Alan P. Venook, William P. Harris, Paige Bracci, Robin K. Kelley
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Early changes in alpha-fetoprotein (AFP) are a promising surrogate endpoint for systemic treatment outcomes in hepatocellular carcinoma (HCC). Objectives: We sought to investigate the utility of AFP response across first-line sorafenib (1
Externí odkaz:
https://doaj.org/article/275573e7669a474d90f5a610034aed89
Autor:
Robin K Kelley, Andrew H Ko
Publikováno v:
Biologics: Targets & Therapy, Vol 2008, Iss Issue 1, Pp 83-95 (2008)
Robin K Kelley, Andrew H KoUniversity of California, San Francisco, Comprehensive Cancer CenterAbstract: Single agent gemcitabine has been the mainstay of therapy for advanced pancreatic cancer over the past decade. Multiple trials of newer chemother
Externí odkaz:
https://doaj.org/article/b03fe3d41223428eac15921ce749ba74
Autor:
Lisa H. Butterfield, Robin K. Kelley, Karen Zhang, Matthew F. Krummel, Alexis J. Combes, Sean C. Bendall, Daniel Ho, Patricia M.B. Favaro, Felix J. Hartmann, Juraj Adamik, Paul V. Munson
Supplementary Figures, Table, Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b4463aa799bb0f5ee58d757735352ac
https://doi.org/10.1158/0008-5472.22730621
https://doi.org/10.1158/0008-5472.22730621
Autor:
Lisa H. Butterfield, Robin K. Kelley, Karen Zhang, Matthew F. Krummel, Alexis J. Combes, Sean C. Bendall, Daniel Ho, Patricia M.B. Favaro, Felix J. Hartmann, Juraj Adamik, Paul V. Munson
α-Fetoprotein (AFP) is expressed by stem-like and poor outcome hepatocellular cancer tumors and is a clinical tumor biomarker. AFP has been demonstrated to inhibit dendritic cell (DC) differentiation and maturation and to block oxidative phosphoryla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d9b6b53430f945404f1b4ac12b9031
https://doi.org/10.1158/0008-5472.c.6626123.v1
https://doi.org/10.1158/0008-5472.c.6626123.v1
Autor:
Paul V. Munson, Juraj Adamik, Felix J. Hartmann, Patricia M.B. Favaro, Daniel Ho, Sean C. Bendall, Alexis J. Combes, Matthew F. Krummel, Karen Zhang, Robin K. Kelley, Lisa H. Butterfield
Publikováno v:
Cancer research, vol 83, iss 9
α-Fetoprotein (AFP) is expressed by stem-like and poor outcome hepatocellular cancer tumors and is a clinical tumor biomarker. AFP has been demonstrated to inhibit dendritic cell (DC) differentiation and maturation and to block oxidative phosphoryla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ae326c8f01cd35bae61823e90a5f91
https://escholarship.org/uc/item/1c49n38t
https://escholarship.org/uc/item/1c49n38t
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Tumor marker levels and cfDNA mutant allele fractions across 19 time intervals for eight patients that were serially monitored via blood draws.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61b33082c375d2591fee9c8fe16cb14
https://doi.org/10.1158/2159-8290.22530579
https://doi.org/10.1158/2159-8290.22530579
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Complete patient-level and mutation-level concordance information, mutation identities, and monitoring status for each patient in study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab3c361da8b38493344f145b6642aa0
https://doi.org/10.1158/2159-8290.22530582.v1
https://doi.org/10.1158/2159-8290.22530582.v1